Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
May 11, 2026 $199.53 -1.00% $202.78 X 98.40% 0
May 11, 2026 $203.66 +1.05% $202.78 V 99.57% 5
May 11, 2026 $202.87 +0.65% $202.78 V 99.96% 10
May 11, 2026 Bearish $202.78 X 0
Apr 28, 2026 $199.97 +1.31% $197.69 V 98.85% 2
Apr 28, 2026 $199.45 +1.05% $197.69 V 99.11% 3
Apr 28, 2026 $198.67 +0.65% $197.69 V 99.50% 5
Apr 28, 2026 Bullish $197.69 X 1
Apr 27, 2026 $201.29 +1.30% $197.38 X 98.02% 0
Apr 27, 2026 $200.78 +1.04% $197.38 X 98.28% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE